These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 24477012)

  • 1. Author's reply to Wolstenholme and Sanfilippo and colleagues.
    Quint JK
    BMJ; 2014 Jan; 348():g1132. PubMed ID: 24477012
    [No Abstract]   [Full Text] [Related]  

  • 2. β blockers for adults with chronic obstructive pulmonary disease.
    Rutten FH; Groenwold RH
    BMJ; 2013 Nov; 347():f7050. PubMed ID: 24277628
    [No Abstract]   [Full Text] [Related]  

  • 3. Replacing β agonists with antimuscarinic drugs in patients with COPD.
    Wolstenholme RJ
    BMJ; 2014 Jan; 348():g1108. PubMed ID: 24477010
    [No Abstract]   [Full Text] [Related]  

  • 4. Major changes in practice and interpreting data from the past.
    Sanfilippo F; Santonocito C; Foex P
    BMJ; 2014 Jan; 348():g1131. PubMed ID: 24477011
    [No Abstract]   [Full Text] [Related]  

  • 5. Beta blockers for patients with lung disease?
    Harv Heart Lett; 2001 Nov; 12(3):2-3. PubMed ID: 11724686
    [No Abstract]   [Full Text] [Related]  

  • 6. [Beta blockers reduce mortality after myocardial infarct - also in COPD patients].
    Markun S
    Praxis (Bern 1994); 2014 Apr; 103(8):471-2. PubMed ID: 24713385
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acute coronary syndromes and chronic obstructive pulmonary disease in the Little Poland Registry for acute coronary syndromes - why aren't we allowed to work?].
    Kurzyna M
    Kardiol Pol; 2010 Mar; 68(3):302-3. PubMed ID: 20491181
    [No Abstract]   [Full Text] [Related]  

  • 8. β-blocker use and mortality in COPD patients after myocardial infarction: a Swedish nationwide observational study.
    Andell P; Erlinge D; Smith JG; Sundström J; Lindahl B; James S; Koul S
    J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25854796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New data on risks and benefits: beta blockers despite asthma? (interview by Dr. Beate Schumacher)].
    Gillissen A
    MMW Fortschr Med; 2011 Jun; 153(24-25):6. PubMed ID: 21721166
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myocardial Infarction Database Initiative.
    Coiro S; Girerd N; Rossignol P; Ferreira JP; Maggioni A; Pitt B; Tritto I; Ambrosio G; Dickstein K; Zannad F
    Eur J Heart Fail; 2017 Feb; 19(2):271-279. PubMed ID: 27774703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of beta-blockers in patients with hypertension and chronic obstructive lung diseases].
    Libov IA; Mravian SR; Nemirovskaia AI
    Kardiologiia; 2004; 44(3):102-5. PubMed ID: 15489839
    [No Abstract]   [Full Text] [Related]  

  • 12. [Controlled rehabilitation of patients with a recent myocardial infarction (author's transl)].
    Rossi P; Tamiz A; Giordano A; Schiavo B; D'Aulerio M; Aina F; Minuco G; Sguazzini Viscontini C; Gaeta V
    G Ital Cardiol; 1978; 8(7):710-20. PubMed ID: 28262
    [No Abstract]   [Full Text] [Related]  

  • 13. β-blockers for COPD inpatients.
    Suissa S; Ernst P
    Thorax; 2012 Nov; 67(11):936-7. PubMed ID: 23100217
    [No Abstract]   [Full Text] [Related]  

  • 14. The reply.
    Bangalore S; Messerli FH
    Am J Med; 2014 Dec; 127(12):e19. PubMed ID: 25481201
    [No Abstract]   [Full Text] [Related]  

  • 15. Beta blockers in acute myocardial infarction.
    Jariwala PV; Lathi P; Ramesh G; Saha D; Chandra KS
    Indian Heart J; 2010; 62(2):148-53. PubMed ID: 21180308
    [No Abstract]   [Full Text] [Related]  

  • 16. [Exercise test in the evaluation of effectiveness of 4 antianginal drugs (author's transl)].
    Figini A; De Ponti C; Campolo L
    G Ital Cardiol; 1974; 4(3):289-95. PubMed ID: 4152383
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment and outcomes in patients with myocardial infarction treated with acute β-blocker therapy: results from the American College of Cardiology's NCDR(®).
    Kontos MC; Diercks DB; Ho PM; Wang TY; Chen AY; Roe MT
    Am Heart J; 2011 May; 161(5):864-70. PubMed ID: 21570515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Blocker use for patients with or at risk for coronary artery disease--reply.
    Bangalore S; Steg PG; Bhatt DL
    JAMA; 2013 Feb; 309(5):439-40. PubMed ID: 23385261
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of beta blockers in cardiovascular diseases and bronchial asthma/COPD].
    Glaab T; Weiss T
    Internist (Berl); 2004 Feb; 45(2):221-7. PubMed ID: 14991165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescribing pattern of angiotensin- converting enzyme inhibitors and beta blockers after acute myocardial infarction.
    Sweileh WM; Shkokani FM; Sawalha AF; Al-Ramahi RJ; Jaradat NA; Zaid AA; Barakat AS
    Saudi Med J; 2005 Nov; 26(11):1837-9. PubMed ID: 16311686
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.